Which vaccines are recommended for travelers older than 9 months traveling to Nigeria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Vaccines for Travelers >9 Months Old to Nigeria

For travelers older than 9 months going to Nigeria, meningococcal ACWY conjugate vaccine (MenACWY) is essential, along with routine immunizations and other travel-specific vaccines based on individual risk factors.

Critical Vaccine: Meningococcal ACWY

Nigeria is located in sub-Saharan Africa's "meningitis belt," making meningococcal vaccination a priority, particularly during the dry season (December–June) 1.

Dosing Schedule for MenACWY:

  • Ages 9-23 months: MenACWY-D requires 2 doses ≥12 weeks apart (may be given as early as ≥8 weeks apart for travelers) 1
  • Ages ≥2 years: Single dose of MenACWY-D, MenACWY-CRM, or MenACWY-TT 1

Important timing consideration: The vaccine should ideally be administered more than one week before departure, as 77% of travel vaccines are given in this timeframe for optimal protection 2.

Additional Essential Vaccines

Yellow Fever

Yellow fever vaccine is required for entry into Nigeria and is critical for preventing a potentially fatal disease with 20-50% mortality in severe cases 3. This vaccine:

  • Can be administered starting at age ≥9 months
  • Provides lifelong protection
  • Must be given at an approved vaccination center for the international certificate to be valid 3

Routine Immunizations to Update

Before considering travel-specific vaccines, ensure all routine vaccinations are current 4, 5:

  • Measles-containing vaccine: Particularly important for children; measles complications are severe and common in areas with poor healthcare infrastructure 6
  • Diphtheria-tetanus-pertussis (DTP): Children 6 weeks-5 years should have 3 doses, 4-8 weeks apart 6
  • Poliomyelitis: One dose at birth, then 3 doses 4-8 weeks apart for children 6 weeks-5 years 6

Hepatitis A

Strongly recommended for all travelers to Nigeria 7, 4:

  • Ages 6-11 months: Single dose before travel (does not count toward routine 2-dose series) 7
  • Ages ≥12 months: Standard 2-dose series

Other Vaccines to Consider Based on Activities

  • Typhoid fever: Most commonly administered travel vaccine; recommended for travelers to areas with poor sanitation 2, 4
  • Hepatitis B: Consider for longer stays or those with potential healthcare exposure 4, 5
  • Rabies: Pre-exposure prophylaxis for extended rural travel or animal contact 4, 5

Critical Timing Considerations

Common pitfall: Starting vaccinations too late. Begin the vaccination process 4-6 weeks before departure to allow adequate time for multi-dose series and optimal immune response 8.

For travelers departing sooner:

  • MenACWY can be accelerated to ≥8 weeks between doses for children 9-23 months 1
  • Single-dose vaccines (yellow fever, MenACWY for ages ≥2 years) can be given closer to departure

Booster Requirements

If the traveler remains at increased risk or returns to Nigeria:

  • Ages <7 years at initial vaccination: Booster at 3 years, then every 5 years 1
  • Ages ≥7 years at initial vaccination: Booster at 5 years, then every 5 years 1

Special Considerations

Healthcare utilization drops dramatically during travel (from 294.8 to 24.2 visits per 10,000 person-days), making pre-travel vaccination even more critical since medical care access will be limited 2.

The meningococcal vaccine should be given before or simultaneously with DTaP to avoid immune interference in children receiving MenACWY-

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.